Pet Eligibility Questionnaire
If you believe that your pet may be eligible for this study, please complete our prescreening questionnaire for owners.
We are studying whether a low-dose radiation treatment to the whole abdomen can safely and effectively help cats with chronic inflammatory enteropathy/bowel disease (CIE). The goals of the study are to find out if this treatment is well-tolerated and to determine the lowest dose that can reduce gut inflammation while keeping side effects to a minimum and, ideally, none. Ultimately, we hope this treatment could help manage CIE symptoms and may reduce or even eliminate the need for daily medications or strict diet for your cat.
The goal of this study is to improve your cat’s chronic inflammatory bowel disease (CIE). We expect that radiation therapy may help control symptoms and could allow your cat to reduce—or even stop—other medications, such as anti-inflammatory or immunosuppressive drugs. We hope that most cats will experience either full remission or at least improvement in symptoms and medication needs for at least 6 months, with early evidence suggesting benefits may last over a year. The study also uses lower radiation doses than those previously tested in cats, which may help reduce side effects while still providing benefits.
You will be responsible for the costs of any tests done before enrollment, including:
The study, funded by the Tufts Zeolla Feline Research Fund, will cover all costs related to:
Your cat will undergo 3 blood tests/diagnostics prior to and after the course of treatment with the purpose of monitoring general health and organ function, and collect serum for gastrointestinal-specific analyses. These blood draws amount to approximately 2 teaspoons of blood at each visit. A total of 3 urine sample will be collected via cystocentesis (needle sampling) at each of these visits. We will also obtain a baseline gastro-intestinal focused ultrasound before and two months after the treatment, to monitor any changes to intestines and pancreas. The ultrasound procedure is non-invasive and will be performed under sedation, as needed based on your pet’s compliance.
Your cat’s treatment for CIE will involve a single course of low-dose radiation therapy to the whole abdomen. A total of 3 (minimum) to 5 (maximum) treatment sessions will be delivered once daily on consecutive business days with a machine called linear accelerator. Each radiotherapy treatment session will be delivered under a brief general anesthesia (approximately 20-40 minutes) to ensure your cat’s safety and accurate treatment delivery. Cats enrolled will undergo physical examination by a veterinarian at each visit to ensure they are healthy and cleared to undergo general anesthesia for treatment each day. A CT scan of the abdomen may be done to create a detailed 3‑dimensional map, however this not required. This helps the treatment team plan the radiation more precisely, which may reduce the risk of side effects to organs like the liver and kidneys, but it is not necessary for the current study.
Your cat will need to fast (no food) starting the night before each treatment session, but water should always be available. Fasting helps reduce the risk of complications from sedation or anesthesia, such as vomiting, regurgitation, and inhaling stomach contents into the lungs (aspiration pneumonia). A small treat or pill pockets are allowed early in the morning for administration any medications. Following each session, your cat can return home and resume normal daily activities.
Your cat may have a small area of fur shaved so that small marks can be applied.These marks help the veterinary team position your cat accurately and consistently for each radiation treatment.
Your cat will need to come in for:
For questions regarding the clinical trial, please email clinicaltrials@tufts.edu.
If you believe that your pet may be eligible for this study, please complete our prescreening questionnaire for owners.
If you believe you have a patient who is eligible for this clinical trial study or you would like additional information from the Clinical Trials Office, complete a referring physician questionnaire.